KR20020007382A - 공유결합으로 올리고머화된 막 파괴성 펩티드 - Google Patents

공유결합으로 올리고머화된 막 파괴성 펩티드 Download PDF

Info

Publication number
KR20020007382A
KR20020007382A KR1020017013492A KR20017013492A KR20020007382A KR 20020007382 A KR20020007382 A KR 20020007382A KR 1020017013492 A KR1020017013492 A KR 1020017013492A KR 20017013492 A KR20017013492 A KR 20017013492A KR 20020007382 A KR20020007382 A KR 20020007382A
Authority
KR
South Korea
Prior art keywords
modified
membrane disrupting
peptide
peptides
modified membrane
Prior art date
Application number
KR1020017013492A
Other languages
English (en)
Korean (ko)
Inventor
로스 오웬 필립스
존 해밀톤 웰시
론다 다르피 후세인
Original Assignee
추후제출
코브라 테라퓨틱스 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9909567.1A external-priority patent/GB9909567D0/en
Priority claimed from GBGB9916912.0A external-priority patent/GB9916912D0/en
Priority claimed from GBGB9928303.8A external-priority patent/GB9928303D0/en
Application filed by 추후제출, 코브라 테라퓨틱스 리미티드 filed Critical 추후제출
Publication of KR20020007382A publication Critical patent/KR20020007382A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43572—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from bees
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Insects & Arthropods (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
KR1020017013492A 1999-04-26 2000-04-25 공유결합으로 올리고머화된 막 파괴성 펩티드 KR20020007382A (ko)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GBGB9909567.1A GB9909567D0 (en) 1999-04-26 1999-04-26 A modified membrane disruptive peptide
GB9909567.1 1999-04-26
US13237699P 1999-05-04 1999-05-04
US60/132,376 1999-05-04
GBGB9916912.0A GB9916912D0 (en) 1999-07-19 1999-07-19 A modified membrane disruptive peptide
GB9916912.0 1999-07-19
GB9928303.8 1999-11-30
GBGB9928303.8A GB9928303D0 (en) 1999-11-30 1999-11-30 A modified membrane disruptive peptide
PCT/GB2000/001588 WO2000064929A1 (en) 1999-04-26 2000-04-25 Membrane disruptive peptides covalently oligomerized

Publications (1)

Publication Number Publication Date
KR20020007382A true KR20020007382A (ko) 2002-01-26

Family

ID=27451899

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020017013492A KR20020007382A (ko) 1999-04-26 2000-04-25 공유결합으로 올리고머화된 막 파괴성 펩티드

Country Status (9)

Country Link
EP (1) EP1173474A1 (zh)
JP (1) JP2002544126A (zh)
KR (1) KR20020007382A (zh)
CN (1) CN1349543A (zh)
AU (1) AU4584800A (zh)
CA (1) CA2370284A1 (zh)
HK (1) HK1044003A1 (zh)
IL (1) IL145885A0 (zh)
WO (1) WO2000064929A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7446099B2 (en) 2004-02-27 2008-11-04 Nitto Denko Corporation Compositions and methods for biodegradable polymer-peptide mediated transfection
CN106589102A (zh) * 2016-11-30 2017-04-26 青岛大学 Orexin‑A聚乙二醇化修饰物制备及用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1010692C2 (nl) * 1998-12-01 2000-06-06 Stichting Tech Wetenschapp Antivirale peptiden.

Also Published As

Publication number Publication date
CN1349543A (zh) 2002-05-15
JP2002544126A (ja) 2002-12-24
AU4584800A (en) 2000-11-10
HK1044003A1 (zh) 2002-10-04
EP1173474A1 (en) 2002-01-23
CA2370284A1 (en) 2000-11-02
WO2000064929A1 (en) 2000-11-02
IL145885A0 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
US6344436B1 (en) Lipophilic peptides for macromolecule delivery
AU2008296733B2 (en) VEGFR-1/NRP-1 targeting peptides
AU705035B2 (en) Nucleic acid transporters for delivery of nucleic acids into a cell
CN107075574A (zh) 铁调素和微型铁调素类似物及其用途
AU2019218786B2 (en) Cell-permeable stapled peptide modules for cellular delivery
US6372720B1 (en) Liposome fusion and delivery vehicle
US6780846B1 (en) Membrane translocating peptide drug delivery system
CA2406233A1 (en) Compositions for drug delivery
US20090011984A1 (en) Biotin-binding receptor molecules
Liu et al. Design, synthesis, and biological evaluation of stapled ascaphin-8 peptides
KR20020007382A (ko) 공유결합으로 올리고머화된 막 파괴성 펩티드
CA2481399A1 (en) Peptides and pharmaceutical compositions comprising said peptides for treating cancer
AU749113B2 (en) Compositions and methods for highly efficient transfection
WO2024041372A1 (zh) 一种用于有效递送核酸的分支链结构多肽载体及其变化形式
CN109134659B (zh) 一种核酸载体及其用途
WO2007037514A1 (ja) ヘパリン結合性上皮増殖因子様増殖因子の新規医薬用途
US20030125239A1 (en) Compositions for drug delivery
WO2004094462A2 (en) Methods of peptide preparation
US20030100496A1 (en) Compositions and methods for highly efficient transfection

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid